XML 22 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net income $ 321,406 $ 333,948 $ 293,487
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 299,563 247,406 184,431
Stock-based compensation 126,677 111,996 95,884
Excess tax benefits from stock-based compensation (29,301) (32,238) (22,801)
Provision (benefit) for deferred income taxes 4,098 (25,880) 27,343
Amortization of debt discount and issuance costs 18,525 15,463 0
Other non-cash reconciling items, net 5,804 2,565 1,176
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:      
Accounts receivable (56,247) (58,397) (67,184)
Prepaid expenses and other current assets 7,137 (60,788) (3,842)
Accounts payable and accrued expenses 51,624 94,698 40,533
Deferred revenue 3,224 7,725 11,495
Other current liabilities (345) (702) 52
Other non-current assets and liabilities 11,986 22,274 3,334
Net cash provided by operating activities 764,151 658,070 563,908
Cash flows from investing activities:      
Cash paid for acquisitions, net of cash acquired (141,147) (386,532) (30,657)
Purchases of property and equipment (311,676) (207,159) (187,964)
Capitalization of internal-use software development costs (133,307) (111,468) (72,109)
Purchases of short- and long-term marketable securities (692,879) (1,225,409) (494,885)
Proceeds from sales of short- and long-term marketable securities 2,008 373,730 160,210
Proceeds from maturities of short- and long-term marketable securities 843,931 372,287 314,925
Other non-current assets and liabilities (2,494) 5,745 (2,628)
Net cash used in by investing activities (435,564) (1,178,806) (313,108)
Cash flows from financing activities:      
Proceeds from the issuance of convertible senior notes, net of issuance costs 0 678,735 0
Proceeds from the issuance of warrants related to convertible senior notes 0 77,970 0
Purchase of note hedge related to convertible senior notes 0 (101,292) 0
Repayment of acquired debt and capital leases 0 (17,862) 0
Proceeds related to the issuance of common stock under stock plans 61,791 87,109 63,707
Excess tax benefits from stock-based compensation 29,301 32,238 22,801
Employee taxes paid related to net share settlement of stock-based awards (54,164) (50,649) (41,332)
Repurchases of common stock (302,606) (268,647) (160,419)
Other non-current assets and liabilities (2,050) (1,575) 0
Net cash provided by (used in) financing activities (267,728) 436,027 (115,243)
Effects of exchange rate changes on cash and cash equivalents (10,036) (10,532) (3,655)
Net increase (decrease) in cash and cash equivalents 50,823 (95,241) 131,902
Cash and cash equivalents at beginning of year 238,650 333,891 201,989
Cash and cash equivalents at end of year 289,473 238,650 333,891
Supplemental disclosure of cash flow information:      
Cash paid for income taxes, net of refunds received in the year ended December 31, 2015 of $19,374 75,033 166,211 63,508
Non-cash financing and investing activities:      
Purchases of property and equipment and capitalization of internal-use software development costs included in accounts payable and accrued expenses 19,327 45,868 19,927
Capitalization of stock-based compensation 17,867 15,226 12,325
Convertible note receivable received for divestiture of a business $ 0 $ 0 $ 18,882